Selective gene expression human heart Quantification steady-state levels messenger RNA endomyocardial biopsies polymerase chain reaction BACKGROUND Evaluation gene expression human heart availability cardiac tissue METHODS RESULTS polymerase chain reaction PCR gene expression small quantities human heart PCR powerful new molecular biological tool small quantity DNA much million-fold Total RNA mg samples human heart reverse-transcribed complementary DNA cDNA oligonucleotide primers PCR cDNAs atrial natriuretic peptide beta-myosin heavy chain phospholamban cytoskeletal beta-actin relative levels messenger RNA mRNA human heart known amount control RNA present reverse transcription PCR reactions amount mRNA sample relation amount control product control RNA synthetic DNA template primers complementary cDNAs interest Atrial natriuretic factor mRNA human heart abundant ventricular myocardium human heart contrast steady-state levels phospholamban mRNA whereas levels beta-myosin heavy-chain mRNA unchanged heart failure CONCLUSIONS Alterations gene expression failing human heart selective addition present study PCR rapid economical way expression multiple genes interest endomyocardial biopsy specimens understanding heart muscle disease 